<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Family history of cancer and childhood rhabdomyosarcoma: a report from the Children&apos;s Oncology Group and the Utah Population Database</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Philip</forename><forename type="middle">J</forename><surname>Lupo</surname></persName>
							<email>philip.lupo@bcm.edu</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Hematology-Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">Baylor College of Medicine</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heather</forename><forename type="middle">E</forename><surname>Danysh</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Hematology-Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">Baylor College of Medicine</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sharon</forename><forename type="middle">E</forename><surname>Plon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Hematology-Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">Baylor College of Medicine</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karen</forename><surname>Curtin</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Center for Children&apos;s Cancer Research (C3R)</orgName>
								<orgName type="institution">University of Utah Health Sciences Center</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of Utah School of Medicine</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Malkin</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="department" key="dep3">The Hospital for Sick Children</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><surname>Hettmer</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Charit e</orgName>
								<orgName type="institution">University Hospital Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Douglas</forename><forename type="middle">S</forename><surname>Hawkins</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Seattle Children&apos;s Hospital</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">Fred Hutchinson Cancer Research Center</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephen</forename><forename type="middle">X</forename><surname>Skapek</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="department" key="dep3">Southwestern Medical Center and Children&apos;s Medical Center</orgName>
								<orgName type="institution">University of Texas</orgName>
								<address>
									<settlement>Dallas</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Logan</forename><forename type="middle">G</forename><surname>Spector</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Division of Pediatric Epidemiology and Clinical Research</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">University of Minnesota</orgName>
								<address>
									<settlement>Minneapolis</settlement>
									<region>Minnesota</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Papworth</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Radiation Sciences, Oncology</orgName>
								<orgName type="institution">Ume a University</orgName>
								<address>
									<settlement>Umea</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Beatrice</forename><surname>Melin</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Radiation Sciences, Oncology</orgName>
								<orgName type="institution">Ume a University</orgName>
								<address>
									<settlement>Umea</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Erik</forename><forename type="middle">B</forename><surname>Erhardt</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Mathematics and Statistics</orgName>
								<orgName type="institution">University of New Mexico</orgName>
								<address>
									<settlement>Albuquerque</settlement>
									<region>New Mexico</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Seymour</forename><surname>Grufferman</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Division of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="institution">University of New Mexico</orgName>
								<address>
									<settlement>Albuquerque</settlement>
									<region>New Mexico</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joshua</forename><forename type="middle">D</forename><surname>Schiffman</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Center for Children&apos;s Cancer Research (C3R)</orgName>
								<orgName type="institution">University of Utah Health Sciences Center</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department">Department of Oncological Sciences</orgName>
								<orgName type="institution">Huntsman Cancer Institute</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of Utah Health Sciences Center</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Department of Pediatrics</orgName>
								<address>
									<addrLine>One Baylor Plaza</addrLine>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>MS: BCM305, TX</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Utah State Department of Health</orgName>
								<orgName type="institution">University of Utah</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Family history of cancer and childhood rhabdomyosarcoma: a report from the Children&apos;s Oncology Group and the Utah Population Database</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">50E14E590A960AD497ADC776EF91799D</idno>
					<idno type="DOI">10.1002/cam4.448</idno>
					<note type="submission">Received: 26 December 2014; Revised: 12 February 2015; Accepted: 19 February 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:18+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Childhood cancer</term>
					<term>epidemiology</term>
					<term>family history</term>
					<term>rhabdomyosarcoma</term>
					<term>soft tissue sarcoma</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Relatively little is known about the epidemiology and factors underlying susceptibility to childhood rhabdomyosarcoma (RMS).</s><s>To better characterize genetic susceptibility to childhood RMS, we evaluated the role of family history of cancer using data from the largest case-control study of RMS and the Utah Population Database (UPDB).</s><s>RMS cases (n = 322) were obtained from the Children's Oncology Group (COG).</s><s>Population-based controls (n = 322) were pair-matched to cases on race, sex, and age.</s><s>Conditional logistic regression was used to evaluate the association between family history of cancer and childhood RMS.</s><s>The results were validated using the UPDB, from which 130 RMS cases were identified and matched to controls (n = 1300) on sex and year of birth.</s><s>The results were combined to generate summary odds ratios (OR s ) and 95% confidence intervals (CI).</s><s>Having a first-degree relative with a cancer history was more common in RMS cases than controls (OR s = 1.39, 95% CI: 0.97-1.98).</s><s>Notably, this association was stronger among those with embryonal RMS (OR s = 2.44, 95% CI: 1.54-3.86).</s><s>Moreover, having a first-degree relative who was younger at diagnosis of cancer (&lt;30 years) was associated with a greater risk of RMS (OR s = 2.37, 95% CI: 1.34-4.18).</s><s>In the largest analysis of its kind, we found that most children diagnosed with RMS did not have a family history of cancer.</s><s>However, our results indicate an increased risk of RMS (particularly embryonal RMS) in children who have a first-degree relative with cancer, and among those whose relatives were diagnosed with cancer at &lt;30 years of age.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Rhabdomyosarcoma (RMS) is a malignant tumor of skeletal muscle.</s><s>While RMS is the most common soft tissue sarcoma in children <ref type="bibr" target="#b0">[1]</ref>, the annual incidence is only 4.6 per million in people younger than 20 years of age <ref type="bibr" target="#b1">[2]</ref>.</s><s>In the United States (US), about 350 children and adolescents are diagnosed with RMS per year <ref type="bibr" target="#b2">[3]</ref>, and half of those cases occur before 10 years of age <ref type="bibr" target="#b1">[2]</ref>.</s><s>The two major histologic subtypes of RMS are embryonal (~70% of cases) and alveolar (~30% of cases).</s><s>While embryonal RMS are characterized by loss of heterozygosity/loss of imprinting at loci on chromosome 11p15, ~80% of alveolar RMS are driven by a specific chromosomal translocation between either of the transcription factors PAX3 or PAX7 and FOXO1 <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>Relatively little is known about the epidemiology and factors underlying susceptibility to childhood RMS.</s><s>Inherited genetic susceptibility is believed to play an important role in the development of childhood RMS <ref type="bibr" target="#b6">[7]</ref>.</s><s>For instance, ~5% of cases appear to be associated with familial syndromes <ref type="bibr" target="#b7">[8]</ref>.</s><s>Specifically, within Li-Fraumeni syndrome (LFS) families that carry germline TP53 mutations, RMS is one of the most common childhood malignancies <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>Additionally, in one report from the fourth trial of the Intergroup Rhabdomyosarcoma Study Group (IRS-IV), the prevalence of neurofibromatosis type 1 was ~20 times greater in children with RMS compared to the general population (0.5% vs. 0.02-0.03%)</s><s><ref type="bibr" target="#b10">[11]</ref>.</s><s>In spite of these associations, much work remains in characterizing the role of genetic susceptibility in the etiology of childhood RMS.</s></p><p><s>Having a family history of cancer has been shown to be associated with childhood cancers including acute lymphoblastic leukemia <ref type="bibr" target="#b11">[12]</ref>, germ cell tumors <ref type="bibr" target="#b12">[13]</ref>, Hodgkin lymphoma, and non-Hodgkin lymphoma <ref type="bibr" target="#b13">[14]</ref>, however, to our knowledge, there have been no systematic population-based studies evaluating the role of family history of cancer in the etiology of childhood RMS.</s><s>Because family history of cancer is often used to determine the influence of inherited susceptibility in cancer risk, we assessed the association between family history of cancer and RMS in the largest case-control study of childhood RMS to date and the Utah Population Database (UPDB).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>COG discovery cohort</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>Cases and controls were enrolled from the third trial previously coordinated by the Intergroup Rhabdomyosarcoma Study Group (IRSG), which became part of the Children's Oncology Group (COG) in 2000 and managed treatment protocols for 80-85% of all childhood RMS cases in North America <ref type="bibr" target="#b14">[15]</ref>.</s><s>The details regarding the case-control study have been previously described <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s><s>Briefly, the cases included those who were 0 years old and up through 20 years of age at the time of their RMS diagnosis from April 1982 to July 1988.</s><s>Central expert pathology review, coordinated by COG, confirmed all RMS diagnoses, as well as histologic subtype (i.e., embryonal, alveolar, or other).</s><s>Controls were identified by random-digit dialing during the same period <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s><s>Controls were pair-matched to cases on race, sex, and age.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data collection and variables</head><p><s>Data were collected from case and control families by telephone interview using a structured questionnaire, which included items on family cancer history among first-and second-degree relatives.</s><s>The child's mother and father were asked to participate in the interview, which for case and control families lasted on average 70 and 68 min, respectively.</s><s>Interviews were conducted in English and Spanish.</s><s>The Institutional Review Board (IRB) at Baylor College of Medicine approved this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>UPDB validation cohort</head><p><s>The UPDB is a dynamic resource located at the University of Utah and consists of computerized statewide vital records, cancer registry information, and administrative claims data for 7.3 million living and deceased individuals, beginning in the early 1900s.</s><s>Most families living in Utah are represented in the UPDB multigenerational pedigrees.</s><s>Data from the Utah Cancer Registry (UCR), a Surveillance Epidemiology and End Results (SEER) registry since 1973, are regularly linked to the UPDB.</s><s>This provides an ongoing and accurate assessment of family history of cancer that does not depend on self-report.</s><s>We identified RMS cases diagnosed at 0-20 years of age from the UCR from 1966 to 2011.</s><s>Unaffected population controls were selected randomly from individuals in UPDB and matched 10:1 to RMS cases on sex and birth year.</s><s>To appropriately match exposure periods, a control had to have follow up at least as long as the date of diagnosis for their respective case.</s><s>COG cases were neither born nor diagnosed in Utah, and therefore, there was no overlap between cases from the COG and UPDB cohorts.</s><s>The University of Utah's IRB and Resource for Genetic Epidemiologic Research approved this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p><s>Descriptive statistics were used to characterize the demographic variables among the case and control groups.</s><s>To compare the potential prevalence of LFS in RMS cases with previous reports, we determined the proportion of cases that met the revised Chompret criteria <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>Specifically, the criteria were met if the case had a firstor second-degree relative diagnosed with (1) at least one tumor classified under the LFS spectrum (e.g., soft tissue sarcoma, osteosarcoma, brain tumor, premenopausal breast cancer, adrenocortical carcinoma, leukemia, lung bronchoalveolar cancer) at &lt;56 years of age, or (2) multiple tumors.</s></p><p><s>For the COG discovery cohort, conditional logistic regression was used to evaluate cancer history among first-and second-degree relatives and the association with childhood RMS by generating adjusted odds ratios (OR a ) and 95% confidence intervals (CI).</s><s>Specifically, cancer history was assessed among first-degree relatives, seconddegree relatives, and any relatives (i.e., either a first-or second-degree relative).</s><s>Stratified analyses were conducted to: (1) evaluate the association of family cancer history and childhood RMS for children who are male and those who are female; (2) children diagnosed under 5 years of age and those diagnosed later (based on sample size and previous assessments) <ref type="bibr" target="#b12">[13]</ref>; and (3) for children who have relatives diagnosed with a malignancy before the age of 30 years and those with relatives diagnosed when older than 30 years.</s><s>Because the RMS histologic subtypes are suspected to be heterogeneous in etiology, the association of family cancer history and childhood RMS was also assessed separately for children diagnosed with embryonal RMS; we did not separately assess those with alveolar RMS due to the potential heterogeneity within this group as information on PAX-FOXO1 fusion status was not available.</s><s>Finally, the association of family cancer history and childhood RMS was independently evaluated among each cancer type diagnosed in their relatives.</s><s>All statistical models were adjusted for the matching factors including the child's sex (male or female), age at diagnosis (in years), and race (categorized as White, Black, or other).</s><s>An association was considered statistically significant if P &lt; 0.05.</s></p><p><s>Analyses were repeated with the UPDB validation cohort using unconditional logistic regression to generate OR a and 95% CIs, adjusting for the matching factors of sex and year of birth.</s><s>The results from the COG discovery cohort and the UPDB validation cohort were combined using weighted standard errors in meta-analysis, due to differences in study design between the cohorts, to generate summary ORs (OR s ) and 95% CIs.</s><s>We tested for heterogeneity across the two studies (i.e., cohorts) using Cochran's Q-test <ref type="bibr" target="#b20">[21]</ref>.</s></p><p><s>All analyses were conducted using STATA 12.1 (Stata-Corp LP, College Station, TX) and SAS 9.1.3</s><s>(SAS Institute, Cary, NC).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>There were 322 case-control pairs available from the COG discovery cohort and 130 RMS cases and 1300 controls from the UPDB validation cohort for the present analysis (Table <ref type="table" target="#tab_0">1</ref>).</s><s>A higher proportion of case mothers (COG 14.1%, UPDB 13.2%) and fathers (COG 17.1%, UPDB 8.6%) had less than a high school education compared to control mothers (COG 12.2%, UPDB 11.1%) and fathers (COG 11.8%, UPDB 7.0%).</s><s>Additionally, a higher proportion of cases (COG 32.8%) were from households where the total annual income was less than $20,000 compared to controls (COG 24.3%).</s><s>The most common histologic subtype of RMS in this population was embryonal (COG 66.7%, UPDB 50.0%) followed by alveolar (COG 20.5%, UPDB 29.2%).</s><s>The prevalence of potential LFS (when applying the revised Chompret criteria) was similar among RMS cases diagnosed at &lt;3 years of age (COG 13.0%, UPDB 12.0%) and those diagnosed at ≥3 years of age (COG 13.3%, UPDB 14.3%).</s></p><p><s>Most RMS cases did not have a first-degree relative with a history of cancer (COG 92.2%, UPDB 94.5%).</s><s>While not statistically significant, having any first-degree relative with cancer was positively associated with childhood RMS (Table <ref type="table" target="#tab_1">2</ref>) (OR s = 1.39, 95% CI: 0.97-1.98).</s><s>The direction and magnitude of the association did not differ based on maternal or paternal history of cancer (COG OR a = 1.33, 95% CI: 0.51-3.44 and COG OR a = 1.30, 95% CI: 0.48-3.51,</s><s>respectively).</s><s>While there were no statistically significant associations between a family history of specific cancer types and childhood RMS in the COG data (Table <ref type="table" target="#tab_0">S1</ref>), there were positive associations with a family history of cancer of the lip or oral cavity (OR a = 2.44, 95% CI: 0.22-27.43),</s><s>melanoma (OR a = 1.44, 95% CI: 0.24-8.68),</s><s>breast (OR a = 1.72, 95% CI: 0.62-4.78),</s><s>and uterus or ovary (OR a = 1.77, 95% CI: 0.41-7.57).</s></p><p><s>Stratified analyses (Table <ref type="table" target="#tab_2">3</ref>) revealed that if the firstdegree relative was &lt;30 years of age when diagnosed with cancer, the association between family history of cancer and childhood RMS was stronger than if the first-degree relative was ≥30 years of age at diagnosis, (COG OR a = 1.69, 95% CI: 0.76-3.78 vs. OR a = 1.32, 95% CI: 0.58-3.01;</s><s>UPDB OR a = 3.33, 95% CI: 1.48-7.46 vs. OR a = 1.14, 95% CI: 0.71-1.83).</s><s>Additionally, when combining the COG and UPDB results, having a first-degree relative diagnosed at &lt;30 years of age was significantly associated with RMS risk (OR s = 2.37, 95% CI: 1.34-4.18).</s><s>In order to determine if this finding was driven in part to LFS, we restricted our analysis to those who did not meet the Chompret criteria (COG OR a = 2.02, 95% CI: 0.67-6.09).</s></p><p><s>When assessing embryonal RMS and the influence of family history of cancer on disease occurrence (Table <ref type="table" target="#tab_3">4</ref>), there was a positive association between having a firstdegree relative with cancer and embryonal RMS (COG OR a = 1.58, 95% CI: 0.61-4.10),</s><s>with a strong and statistically significant association detected in the UPDB cohort (OR a = 2.78, 95% CI: 1.22-3.50).</s><s>When combining the  COG and UPDB results, having a first-degree relative with a history of cancer was significantly associated with embryonal RMS (OR s = 2.44, 95% CI: 1.54-3.86).</s><s>There was no association between having a second-degree relative with cancer and embryonal RMS in the COG cohort, however, a positive nonsignificant association was detected in the UPDB cohort (OR a = 1.21, 95% CI: 0.89-1.63).</s></p><p><s>There was no heterogeneity detected between the COG and UPDB cohorts when combining results to generate OR s estimates (P for heterogeneity &gt;0.100).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In the largest analysis of its kind to date, we found that most RMS cases did not have a first-degree relative with a history of cancer.</s><s>However, three patterns emerged: <ref type="bibr" target="#b0">(1)</ref> having any first-degree relative with a history of cancer was more common in RMS cases than controls; (2) having a first-degree relative who was younger (&lt;30 years of age) when diagnosed with cancer was more strongly associated with childhood RMS than having a first-degree relative who was older at diagnosis (≥30 years of age); and</s></p><p><s>(3) having a first-degree relative with cancer was strongly associated with embryonal RMS.</s></p><p><s>While there have been no previous population-based studies of family history of cancer and childhood RMS, our results are consistent with previously reported associations between family history of cancer and other childhood cancers.</s><s>For instance, in a case-control study conducted in Canada, the authors reported a positive but nonsignificant association between a family history of cancer among first-degree relatives and childhood acute lymphoblastic leukemia (OR = 1.2, 95% CI: 0.6-2.3) 2 COG, Includes grandparents, aunts, and uncles; UPDB, also includes nieces and nephews.</s><s><ref type="bibr" target="#b11">[12]</ref>.</s><s>Data from the French national population-based ESCALE study indicated that a family history of cancer was associated with an increased risk of Hodgkin lymphoma (OR = 1.5, 95% CI: 1.0-2.2) and non-Hodgkin lymphoma (OR = 1.8, 95% CI: 1.3-2.5)</s><s><ref type="bibr" target="#b13">[14]</ref>.</s><s>The magnitude of these associations is similar to our findings.</s><s>As in our study, the ESCALE study reported associations were stronger when the relative was first-degree (e.g., Hodgkin lymphoma OR = 2.2, 95% CI: 0.9-5.1)</s><s>versus second degree (OR = 1.4,</s><s>95% CI: 1.0-2.1).</s><s>Additionally, the ORs were higher when relatives were diagnosed earlier in life (&lt;46 years of age), which was also the case in our population.</s><s>This is further supported by a report from the COG where the association between family history of cancer and germ cell tumors in male children was stronger when the relative was &lt;40 years of age at diagnosis (OR = 2.6, 95% CI: 1.0-6.44)</s><s>compared to when the relative was 40-49 years of age at diagnosis (OR = 1.2, 95% CI: 0.5-3.4) or ≥50 years of age at diagnosis (OR = 1.3, 95% CI: 0.60-2.73)</s><s><ref type="bibr" target="#b12">[13]</ref>.</s></p><p><s>Case reports and case series of childhood RMS have indicated that a family history of cancer or of a cancerpredisposing syndrome is an important factor in disease risk.</s><s>Li and Fraumeni reported that among 648 childhood RMS cases, four were from families in which siblings or cousins had a childhood sarcoma <ref type="bibr" target="#b21">[22]</ref>.</s><s>These families also had histories of breast cancer and other neoplasms.</s><s>While not statistically significant, in our population, a family history of breast cancer was positively associated with childhood RMS (OR a = 1.72, 95% CI: 0.62-4.78).</s><s>Among children who were &lt;3 years of age at diagnosis, 13.3% and 12.0% had a family history of cancer consistent with that of LFS in the COG and UPDB cohorts, respectively.</s><s>This supports previous reports that estimate 10-15% of younger children (i.e., &lt;3 years of age) diagnosed with RMS may have LFS <ref type="bibr" target="#b22">[23]</ref>.</s><s>Additionally, in our data ~13-14% children ≥3 years of age at diagnosis also met the Chompret criteria for potential LFS.</s><s>This is in contrast to a previous report which suggested that LFS may not be as common among those older than 3 years of age at diagnosis <ref type="bibr" target="#b23">[24]</ref>.</s><s>Furthermore, these estimates were confirmed in the UPDB cohort.</s></p><p><s>Our results further indicate that the RMS risk among children with first-degree relatives that were younger at cancer diagnosis (&lt;30 years of age) was not driven by LFS.</s><s>This could indicate that other cancer susceptibility genes that are yet to be identified may underlie RMS.</s></p><p><s>As indicated, in our study, family history of cancer was more strongly associated with embryonal RMS than when assessing all RMS cases together.</s><s>This is notable as embryonal RMS is characterized by a younger age at onset compared to alveolar RMS <ref type="bibr" target="#b24">[25]</ref>, and there is some evidence that embryonal RMS is more common than alveolar RMS in families with TP53 mutations <ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref>.</s><s>Interestingly, anaplastic RMS also appears to be associated with germline TP53 mutations <ref type="bibr" target="#b28">[29]</ref>.</s><s>Unfortunately, anaplastic histology was not annotated in IRS-III or the UPDB.</s><s>Lastly, in a hospital-based survey, investigators observed that relatives of sarcoma patients were more likely to have an excess of cancer when the sarcoma histologic type was embryonal RMS <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>This may point to a stronger role of family history of cancer in the development of embryonal RMS when compared with alveolar RMS; however, this must be further investigated.</s></p><p><s>Our results should be considered in light of certain limitations.</s><s>First, family history of disease was obtained by self-report for the COG cohort.</s><s>Self-report of family history of cancer is relatively accurate in case-control studies; however, reliability appears to be higher for reports for first-degree relatives compared to more distant relatives <ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref>.</s><s>Although we evaluated associations between both first-(parents and siblings) and seconddegree (grandparents and aunts/uncles) relatives, as parents provided family history information about their firstdegree relatives (i.e., the child's grandparents and aunts/ uncles), we might expect the information about a child's second-degree relative to be more accurate than in comparable studies of adult cancers.</s><s>Parents of cases might also be expected to give a more thorough history than control parents, although this is not supported by three previous validation studies <ref type="bibr" target="#b32">[33,</ref><ref type="bibr" target="#b36">36,</ref><ref type="bibr" target="#b37">37]</ref>.</s><s>Lastly, our results were validated using the UPDB, which is a populationbased resource that relies on record linkages between birth certificates, the UCR, and medical records to follow cancer diagnoses through family pedigrees.</s><s>Associations found in the UPDB cohort were consistent, and sometimes stronger when compared with the COG cohort (i.e., the OR for having a first-degree relative with cancer among those with embryonal RMS was 76% stronger in the UPDB compared to the COG cohort).</s></p><p><s>Another limitation is that while this is the largest casecontrol study of childhood RMS to date, we were restricted to evaluating only first-and second-degree relatives.</s><s>Additionally, due to small numbers, it was not possible to assess disease risk associated with increasing number of relatives with a previous cancer diagnosis.</s><s>For instance, in the COG population, less than 1% of subjects had two first-degree relatives with a history of cancer.</s></p><p><s>Recent findings confirm that ~20% of alveolar RMS tumors do not exhibit a PAX-FOXO1 rearrangement <ref type="bibr" target="#b38">[38]</ref>, and that "fusion negative" alveolar RMS cases have clinical outcomes similar to those with embryonal RMS <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b39">39,</ref><ref type="bibr" target="#b40">40]</ref>.</s><s>In fact, the biology of fusion negative alveolar RMS tumors may be closer to embryonal RMS tumors, suggesting these two phenotypes could be considered together in epidemiologic assessments.</s><s>Unfortunately, PAX-FOX01 fusions were not assessed when the COG cases were diagnosed in the 1980s; therefore it is not possible to evaluate the influence of family cancer history on RMS based on fusion status.</s><s>However, it is not clear if risk factors for embryonal RMS and fusion negative alveolar RMS overlap.</s><s>Furthermore, several previous epidemiologic assessments have evaluated embryonal RMS as a distinct phenotype <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b41">41]</ref>.</s></p><p><s>This study has several major strengths.</s><s>First, this is the largest case-control study to evaluate the influence of family history of cancer on childhood RMS, with 322 childhood RMS cases from the COG cohort.</s><s>Second, this study is unique in that it provides a population-based estimate of potential LFS among those with RMS.</s><s>Lastly, we validated our findings (COG) in a second independent cohort (UPDB).</s><s>While this is common for large-scale genetic studies, it is not typically practiced in classical epidemiologic assessments.</s></p><p><s>While only a minority of children with RMS had a family history of cancer, this study adds to the body of evidence that inherited genetic susceptibility may be a factor in the development of childhood RMS.</s><s>This is reflected in a modest increase (i.e., 39%) in familial cancer incidence and earlier onset of these malignancies.</s><s>Much work remains in characterizing germline genetic susceptibility to childhood RMS.</s><s>Unlike many other childhood cancers, there have been few germline candidate gene studies of RMS and no genome-wide association studies to date.</s><s>As little is known about the epidemiology of childhood RMS, it will be important to further examine the genetic underpinnings of these complex phenotypes in future studies.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>ª</head><label></label><figDesc><div><p><s>2015 The Authors.</s><s>Cancer Medicine published by John Wiley &amp; Sons Ltd.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Demographic characteristics among cases and controls.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Children's Oncology Group</cell><cell>Utah Population Database</cell><cell></cell></row><row><cell>Characteristic</cell><cell>Controls (n = 322)</cell><cell>Cases (n = 322)</cell><cell>Controls (n = 1300)</cell><cell>Cases (n = 1300)</cell></row><row><cell>Child</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Sex, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Male</cell><cell>215 (66.8)</cell><cell>215 (66.8)</cell><cell>690 (53.1)</cell><cell>69 (53.1)</cell></row><row><cell>Female</cell><cell>107 (33.2)</cell><cell>107 (33.2)</cell><cell>610 (46.9)</cell><cell>61 (46.9)</cell></row><row><cell>Race, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>White</cell><cell>291 (90.4)</cell><cell>287 (89.1)</cell><cell>1215 (93.5)</cell><cell>127 (97.7)</cell></row><row><cell>Non-white</cell><cell>31 (9.6)</cell><cell>35 (10.9)</cell><cell>85 (6.5)</cell><cell>3 (2.3)</cell></row><row><cell>Ethnicity, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Non-Hispanic</cell><cell>307 (95.9)</cell><cell>303 (94.7)</cell><cell>1233 (95.9)</cell><cell>122 (93.8)</cell></row><row><cell>Hispanic</cell><cell>13 (4.1)</cell><cell>17 (5.3)</cell><cell>53 (4.1)</cell><cell>8 (6.2)</cell></row><row><cell>Age at diagnosis/enrollment (years), mean (SD)</cell><cell>7.5 (5.4)</cell><cell>7.6 (5.3)</cell><cell>8.4 (6.2)</cell><cell>8.4 (6.2)</cell></row><row><cell>Parents</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Maternal education, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;High school</cell><cell>39 (12.2)</cell><cell>45 (14.1)</cell><cell>116 (11.1)</cell><cell>15 (13.2)</cell></row><row><cell>High school</cell><cell>126 (39.4)</cell><cell>132 (41.4)</cell><cell>342 (32.7)</cell><cell>39 (34.2)</cell></row><row><cell>&gt;High school</cell><cell>155 (48.4)</cell><cell>142 (44.5)</cell><cell>589 (56.2)</cell><cell>60 (52.6)</cell></row><row><cell>Paternal education, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;High school</cell><cell>37 (11.8)</cell><cell>54 (17.1)</cell><cell>68 (7.0)</cell><cell>9 (8.6)</cell></row><row><cell>High school</cell><cell>111 (35.5)</cell><cell>112 (35.3)</cell><cell>242 (24.9)</cell><cell>24 (23.1)</cell></row><row><cell>&gt;High school</cell><cell>165 (52.7)</cell><cell>151 (47.6)</cell><cell>663 (68.1)</cell><cell>71 (68.3)</cell></row><row><cell>Annual household income, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;$20,000</cell><cell>77 (24.3)</cell><cell>104 (32.8)</cell><cell></cell><cell></cell></row><row><cell>$20,000-$39,999</cell><cell>155 (48.9)</cell><cell>131 (41.3)</cell><cell></cell><cell></cell></row><row><cell>≥$40,000</cell><cell>85 (26.8)</cell><cell>82 (25.9)</cell><cell></cell><cell></cell></row><row><cell>Rhabdomyosarcoma</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Histologic subtypes, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Embryonal</cell><cell></cell><cell>215 (66.7)</cell><cell></cell><cell>65 (50.0)</cell></row><row><cell>Alveolar</cell><cell></cell><cell>66 (20.5)</cell><cell></cell><cell>38 (29.2)</cell></row><row><cell>NOS</cell><cell></cell><cell>41 (12.8)</cell><cell></cell><cell>27 (20.8)</cell></row><row><cell>Potential Li-Fraumeni syndrome 1</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Diagnosed at &lt;3 years old</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell></cell><cell>65 (86.7)</cell><cell></cell><cell>22 (88.0)</cell></row><row><cell>Yes</cell><cell></cell><cell>10 (13.3)</cell><cell></cell><cell>3 (12.0)</cell></row><row><cell>Diagnosed at ≥3 years old</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell></cell><cell>215 (87.0)</cell><cell></cell><cell>90 (85.7)</cell></row><row><cell>Yes</cell><cell></cell><cell>32 (13.0)</cell><cell></cell><cell>15 (14.3)</cell></row><row><cell>NOS, not otherwise specified.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>1 Determined using the revised Chompret criteria [19, 20].</s><s>784 ª 2015 The Authors.</s><s>Cancer Medicine published by John Wiley &amp; Sons Ltd.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Family history of cancer in first-and second-degree relatives and risk of childhood rhabdomyosarcoma.</s></p></div></figDesc><table><row><cell></cell><cell>95% CI</cell><cell></cell><cell></cell><cell>Reference</cell><cell>0.93-2.0</cell><cell></cell><cell>Reference</cell><cell>NE 2</cell><cell></cell><cell>Reference</cell><cell>0.97-1.98</cell><cell></cell><cell></cell><cell>Reference</cell><cell>0.99-1.24</cell><cell></cell><cell>Reference</cell><cell>0.96-1.35</cell><cell></cell></row><row><cell>Combined</cell><cell>OR s</cell><cell></cell><cell></cell><cell>1.0</cell><cell>1.36</cell><cell></cell><cell>1.0</cell><cell>NE 2</cell><cell></cell><cell>1.0</cell><cell>1.39</cell><cell></cell><cell></cell><cell>1.0</cell><cell>1.11</cell><cell></cell><cell>1.0</cell><cell>1.13</cell><cell></cell></row><row><cell></cell><cell>95% CI</cell><cell></cell><cell></cell><cell>Reference</cell><cell>0.85-2.11</cell><cell></cell><cell>Reference</cell><cell>0.54-3.72</cell><cell></cell><cell>Reference</cell><cell>0.90-2.06</cell><cell></cell><cell></cell><cell>Reference</cell><cell>0.90-1.14</cell><cell></cell><cell>Reference</cell><cell>0.97-1.43</cell><cell></cell></row><row><cell>n = 130; controls, n = 1300)</cell><cell>Controls, n (%) OR 1</cell><cell></cell><cell></cell><cell>932 (84.9) 1.0</cell><cell>166 (15.1) 1.34</cell><cell></cell><cell>857 (96.8) 1.0</cell><cell>28 (3.2) 1.42</cell><cell></cell><cell>983 (84.6) 1.0</cell><cell>179 (15.4) 1.36</cell><cell></cell><cell></cell><cell>388 (41.6) 1.0</cell><cell>544 (58.4) 1.13</cell><cell></cell><cell>560 (48.2) 1.0</cell><cell>602 (51.8) 1.18</cell><cell></cell></row><row><cell>COG (cases, n = 322; controls, n = 322) UPDB (cases,</cell><cell>Family cancer history Cases, n (%) Controls, n (%) OR 1 95% CI Cases, n (%)</cell><cell>First-degree relative</cell><cell>Parents</cell><cell>No 288 (93.8) 293 (95.4) 1.0 Reference 95 (80.5)</cell><cell>Yes 19 (6.2) 14 (4.6) 1.42 0.71-2.85 23 (19.5)</cell><cell>Siblings</cell><cell>No 238 (99.6) 238 (99.6) 1.0 Reference 98 (97.0)</cell><cell>Yes 1 (0.4) 1 (0.4) NE 2 NE 2 3 (3.0)</cell><cell>Any</cell><cell>No 248 (92.2) 262 (94.6) 1.0 Reference 96 (80.0)</cell><cell>Yes 21 (7.8) 15 (5.4) 1.46 0.72-2.97 24 (20.0)</cell><cell>Second-degree</cell><cell>relative 3</cell><cell>No 137 (47.9) 132 (46.2) 1.0 Reference 40 (38.5)</cell><cell>Yes 149 (52.1) 154 (53.8) 0.92 0.66-1.29 64 (61.5)</cell><cell>First-or second-degree relative</cell><cell>No 98 (39.5) 97 (39.1) 1.0 Reference 44 (36.7)</cell><cell>Yes 150 (60.5) 151 (60.9) 0.98 0.68-1.42 76 (63.3)</cell><cell>COG, Children's Oncology Group; UPDB, Utah Population Database; OR, odds ratio; NE, not estimated.</cell></row></table><note><p><s>1COG, adjusted for sex, age, and race; UPDB, adjusted for sex and year of birth. 2 COG, not estimated due to small cells; Combined, not estimated because unable to generate estimates for the COG cohort.3</s><s>COG, includes grandparents, aunts, and uncles; UPDB, also includes nieces and nephews.</s><s>ª 2015 The Authors.</s><s>Cancer Medicine published by John Wiley &amp; Sons Ltd.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Family history of cancer in first-or second-degree relatives and risk of childhood rhabdomyosarcoma: stratified results.</s></p></div></figDesc><table><row><cell></cell><cell cols="3">COG (cases, n = 322; controls, n = 322)</cell><cell cols="3">UPDB (cases, n = 130; controls, n = 1300)</cell><cell>Combined</cell></row><row><cell>Family cancer history</cell><cell cols="3">Cases, n (%) Controls, n (%) OR 1 95% CI</cell><cell cols="3">Cases, n (%) Controls, n (%) OR 1 95% CI</cell><cell>OR s 95% CI</cell></row><row><cell>First-degree relative</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Child's sex</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Male</cell><cell>15 (9.2)</cell><cell>9 (5.5)</cell><cell cols="2">1.55 0.67-3.60 10 (8.3)</cell><cell>103 (8.9)</cell><cell cols="2">0.83 0.40-1.56 1.06 0.63-1.80</cell></row><row><cell>Female</cell><cell>5 (7.1)</cell><cell>4 (5.7)</cell><cell cols="2">1.32 0.34-5.15 14 (11.7)</cell><cell>76 (6.5)</cell><cell cols="2">2.02 1.16-3.39 1.91 1.16-3.14</cell></row><row><cell cols="2">Child's age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;5 years</cell><cell>5 (7.0)</cell><cell>3 (4.2)</cell><cell>1.37 0.29-6.35</cell><cell>7 (5.8)</cell><cell>48 (4.1)</cell><cell cols="2">1.68 0.76-3.40 1.62 0.82-3.17</cell></row><row><cell>≥5 years</cell><cell>13 (9.4)</cell><cell>10 (7.2)</cell><cell cols="2">1.29 0.56-2.94 17 (14.2)</cell><cell>131 (11.3)</cell><cell cols="2">1.23 0.73-1.99 1.25 0.81-1.91</cell></row><row><cell cols="2">Relatives' youngest age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;30 years</cell><cell>6 (2.9)</cell><cell>2 (1.0)</cell><cell>1.69 0.76-3.78</cell><cell>5 (4.2)</cell><cell>20 (1.7)</cell><cell cols="2">3.33 1.48-7.46 2.37 1.34-4.18</cell></row><row><cell>≥30 years</cell><cell>13 (5.8)</cell><cell>10 (4.5)</cell><cell cols="2">1.32 0.58-3.01 19 (16.7)</cell><cell>166 (14.3)</cell><cell cols="2">1.14 0.71-1.83 1.18 0.78-1.78</cell></row><row><cell cols="2">Second-degree relative 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Child's sex</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Male</cell><cell>108 (57.5)</cell><cell>105 (55.9)</cell><cell cols="2">1.05 0.69-1.61 33 (31.7)</cell><cell>293 (31.4)</cell><cell cols="2">1.27 0.93-1.72 1.19 0.93-1.53</cell></row><row><cell>Female</cell><cell>41 (41.8)</cell><cell>49 (50.0)</cell><cell cols="2">0.77 0.44-1.33 31 (29.8)</cell><cell>251 (26.9)</cell><cell cols="2">1.01 0.74-1.37 0.95 0.72-1.24</cell></row><row><cell cols="2">Child's age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;5 years</cell><cell>48 (44.9)</cell><cell>49 (45.8)</cell><cell cols="2">1.02 0.58-1.78 12 (11.5)</cell><cell>156 (16.7)</cell><cell cols="2">0.68 0.41-1.08 0.81 0.56-1.17</cell></row><row><cell>≥5 years</cell><cell>85 (57.8)</cell><cell>90 (61.9)</cell><cell cols="2">0.85 0.52-1.37 52 (50.0)</cell><cell>388 (41.6)</cell><cell cols="2">1.33 1.04-1.70 1.21 0.98-1.51</cell></row><row><cell cols="2">Relatives' youngest age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;30 years</cell><cell>9 (11.5)</cell><cell>5 (6.4)</cell><cell>1.38 0.78-2.42</cell><cell>3 (2.9)</cell><cell>29 (3.1)</cell><cell cols="2">1.14 0.40-3.24 1.32 0.80-2.17</cell></row><row><cell>≥30 years</cell><cell>115 (47.3)</cell><cell>122 (50.2)</cell><cell cols="2">0.89 0.62-1.27 63 (60.6)</cell><cell>529 (56.8)</cell><cell cols="2">1.13 0.91-1.41 1.06 0.88-1.28</cell></row><row><cell cols="2">First-or second-degree relative</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Child's sex</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Male</cell><cell>111 (66.1)</cell><cell>104 (61.9)</cell><cell cols="2">1.21 0.76-1.93 37 (30.8)</cell><cell>323 (27.8)</cell><cell cols="2">1.18 0.88-1.54 1.19 0.94-1.51</cell></row><row><cell>Female</cell><cell>39 (48.8)</cell><cell>47 (58.8)</cell><cell cols="2">0.71 0.37-1.36 26 (21.7)</cell><cell>290 (25.0)</cell><cell cols="2">1.20 0.91-1.56 1.11 0.87-1.43</cell></row><row><cell cols="2">Child's age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;5 years</cell><cell>46 (54.8)</cell><cell>46 (54.8)</cell><cell cols="2">1.06 0.57-1.97 18 (15.0)</cell><cell>169 (14.5)</cell><cell cols="2">0.86 0.56-1.27 0.92 0.65-1.29</cell></row><row><cell>≥5 years</cell><cell>91 (65.9)</cell><cell>92 (66.7)</cell><cell cols="2">1.00 0.60-1.67 58 (48.3)</cell><cell>433 (37.3)</cell><cell cols="2">1.32 1.06-1.64 1.27 1.04-1.55</cell></row><row><cell cols="2">Relatives' youngest age at diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;30 years</cell><cell>10 (18.9)</cell><cell>5 (9.4)</cell><cell>1.43 0.78-2.61</cell><cell>7 (5.8)</cell><cell>28 (2.4)</cell><cell cols="2">2.07 1.10-3.86 1.71 1.11-2.64</cell></row><row><cell>≥30 years</cell><cell>110 (55.0)</cell><cell>115 (57.5)</cell><cell cols="2">0.95 0.63-1.42 72 (60.0)</cell><cell>586 (50.4)</cell><cell cols="2">1.14 0.93-1.39 1.10 0.92-1.32</cell></row><row><cell cols="5">COG, Children's Oncology Group; UPDB, Utah Population Database; OR, odds ratio.</cell><cell></cell><cell></cell></row></table><note><p><s>1COG, adjusted for sex, age, and race; UPDB, adjusted for sex and year of birth.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Associations of family history of cancer and embryonal rhabdomyosarcoma.</s></p></div></figDesc><table><row><cell>Family cancer</cell><cell>COG, n = 215</cell><cell></cell><cell></cell><cell></cell><cell>UPDB, n = 65</cell><cell></cell><cell>Combined</cell></row><row><cell>history</cell><cell cols="3">Cases, n (%) Controls, n (%) OR 1</cell><cell>95% CI</cell><cell cols="3">Cases, n (%) Controls, n (%) OR 1</cell><cell>95% CI</cell><cell>OR 1</cell><cell>95% CI</cell></row><row><cell>First-degree</cell><cell>12 (8.2)</cell><cell>7 (4.8)</cell><cell cols="3">1.58 0.61-4.10 14 (11.7)</cell><cell>87 (7.5)</cell><cell>2.78 1.22-3.50 2.44 1.54-3.86</cell></row><row><cell>relative</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Second-degree</cell><cell>103 (53.9)</cell><cell>105 (55.0)</cell><cell cols="3">0.97 0.64-1.46 33 (31.7)</cell><cell>279 (29.2)</cell><cell>1.21 0.89-1.63 1.12 0.88-1.43</cell></row><row><cell>relative 2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Any first-or</cell><cell>100 (61.4)</cell><cell>100 (61.4)</cell><cell cols="3">1.04 0.66-1.64 76 (63.3)</cell><cell>602 (51.8)</cell><cell>1.38 1.06-1.79 1.29 1.03-1.61</cell></row><row><cell>second-degree</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>relative</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">COG, Children's Oncology Group; UPDB, Utah Population Database; OR, odds ratio.</cell><cell></cell></row><row><cell cols="6">1 COG, adjusted for sex, age, and race; UPDB, adjusted for sex and year of birth.</cell><cell></cell></row><row><cell cols="7">2 COG, Includes grandparents, aunts, and uncles; UPDB, also includes nieces and nephews.</cell></row></table><note><p><s>ª 2015 The Authors.</s><s>Cancer Medicine published by John Wiley &amp; Sons Ltd.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">ª 2015 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.Family history of cancer and rhabdomyosarcoma P. J. Lupo et al.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank the Pedigree and Population Resource (funded by the Huntsman Cancer Foundation) for its role in the ongoing collection, maintenance, and support of the Utah Population Database.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p><s>None declared.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><p><s>Additional Supporting Information may be found in the online version of this article: Table <ref type="table">S1</ref>.</s><s>Family history of cancer types and risk of childhood RMS.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cancer incidence among children and adolescents in the United States</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Pollack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="e1470" to="e1477" />
			<date type="published" when="2001">2008. 2001-2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Soft tissue sarcomas. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Gurney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Young</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Roffers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Bunin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">National Cancer Institute SEER Program</title>
		<imprint>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Children&apos;s Oncology Group&apos;s 2013 blueprint for research: soft tissue sarcomas</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Hawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Skapek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr. Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1001" to="1008" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classificationan Intergroup Rhabdomyosarcoma Study</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Gehan</surname></persName>
		</author>
		<author>
			<persName><surname>Webber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Unnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Hamoudi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="1073" to="1085" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Barr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="5736" to="5746" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma</title>
		<author>
			<persName><forename type="first">D</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Missiaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Reyni Es</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pierron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Thuille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Palenzuela</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2151" to="2158" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Carozza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Horel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Mclaughlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="227" to="231" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A population-based study of familial soft tissue tumors</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hemminki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="411" to="416" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Bergemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hainaut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="1387" to="1396" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms</title>
		<author>
			<persName><forename type="first">D</forename><surname>Malkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Fraumeni</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">250</biblScope>
			<biblScope unit="page" from="1233" to="1238" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV</title>
		<author>
			<persName><forename type="first">L</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Arndt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Raney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Pappo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pediatr</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="666" to="668" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Family history of hematopoietic and other cancers in children with acute lymphoblastic leukemia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Infante-Rivard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guiguet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Detect. Prev</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="83" to="87" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Family history of cancer and malignant germ cell tumors in children: a report from the Children&apos;s Oncology Group</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Poynter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Radzom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Puumala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Robison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Causes Control</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="181" to="189" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Family history of cancer in children with acute leukemia, Hodgkin&apos;s lymphoma or non-Hodgkin&apos;s lymphoma: the ESCALE study (SFCE)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rudant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Menegaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leverger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Baruchel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nelken</surname></persName>
		</author>
		<author>
			<persName><surname>Bertrand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="119" to="126" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">An approach to conducting epidemiologic research within cooperative clinical trials groups</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grufferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Delzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Delong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="670" to="675" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prenatal X-ray exposure and rhabdomyosarcoma in children: a report from the Children&apos;s Oncology Group</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grufferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ruymann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Erhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Maurer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol. Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1271" to="1276" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Parents&apos; use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grufferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Ruymann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Maurer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Causes Control</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="217" to="224" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects</title>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grufferman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Khoury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kowalski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Ruymann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="467" to="474" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Sensitivity and predictive value of criteria for p53 germline mutation screening</title>
		<author>
			<persName><forename type="first">A</forename><surname>Chompret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stoppa-Lyonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Brugi Eres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pag Es</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Feunteun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="43" to="47" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">2009 version of the Chompret criteria for Li Fraumeni syndrome</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tinat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bougeard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baert-Desurmont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vasseur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bouvignies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="e108" to="e109" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>author reply e10</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The combination of estimates from different experiments</title>
		<author>
			<persName><forename type="first">W</forename><surname>Cochran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="101" to="129" />
			<date type="published" when="1954">1954</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Fraumeni</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Intern. Med</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="747" to="752" />
			<date type="published" when="1969">1969</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">Principles and practice of pediatric oncology</title>
		<author>
			<persName><forename type="first">S</forename><surname>Plon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Malkin</surname></persName>
		</author>
		<editor>P. Pizzo and D. Poplack</editor>
		<imprint>
			<date type="published" when="2010">2010</date>
			<publisher>Lippincott Williams &amp; Wilkins</publisher>
			<biblScope unit="page" from="17" to="37" />
			<pubPlace>Baltimore, MD</pubPlace>
		</imprint>
	</monogr>
	<note>Childhood cancer &amp; heredity</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Diller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sexsmith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Malkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="1606" to="1611" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Trends in childhood rhabdomyosarcoma incidence and survival in the United States</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Linabery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Charbonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="4218" to="4226" />
			<date type="published" when="1975">2009. 1975-2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Li-Fraumeni syndrome in a Malaysian kindred</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ariffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Martel-Planche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Daud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hainaut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Genet. Cytogenet</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="49" to="53" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Low prevalence of TP53 mutations and MDM2 amplifications in pediatric rhabdomyosarcoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Martel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Manivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hainaut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sarcoma</title>
		<imprint>
			<biblScope unit="page">492086</biblScope>
			<date type="published" when="2012">2012. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Multiple malignancies in a child with de novo TP53 mutation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wozniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fryer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H. Mc</forename><surname>Dowell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr. Hematol. Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="338" to="343" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hettmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Archer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Somers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Novokmet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Wagers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Diller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="1068" to="1075" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Lustbader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Bondy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Strom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Strong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Hum. Genet</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="344" to="356" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cancer in survivors of childhood soft tissue sarcoma and their relatives</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Norsted</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl. Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="1213" to="1220" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Family history of cancer in patients with glioma: a validation study of accuracy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Airewele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Adatto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mastromarino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sharp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl. Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="543" to="544" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Comparison of self-reported and database-linked family history of cancer data in a case-control study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Kerber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Slattery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="244" to="248" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The accuracy of patient reports of a family history of cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Josten</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Chronic Dis</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="289" to="293" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Murff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Spigel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Syngal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="1480" to="1489" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">The Authors</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>John Wiley &amp; Sons Ltd</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Accuracy of reporting of family history of colorectal cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brewster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Porteous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Wyllie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Bird</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="291" to="295" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Reliability of cancer family history reported by parents in a case-control study of childhood leukemia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Infante-Rivard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Roncarolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Doucette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Causes Control</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1665" to="1672" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children&apos;s Oncology Group</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Rudzinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Teot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Barr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Clin. Pathol</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="82" to="90" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a Children&apos;s Oncology Group report</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Skapek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gastier-Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Parham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr. Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1411" to="1417" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification</title>
		<author>
			<persName><forename type="first">E</forename><surname>Missiaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Williamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chisholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wirapati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pierron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Petel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1670" to="1677" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: a Children&apos;s Oncology Group study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ognjanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Puumala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Robison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Olshan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr. Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="602" to="608" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
